View all available purchase options and get full access to this article. The following represents disclosure information provided by authors of this manuscript. All relationships are considered ...
A Phase I/IIa clinical trials co-led by Linda Laux, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, show that ...
Fayetteville patients will soon have expanded access to advanced cancer treatments through a new oncology clinical trial ...
Research found just 4% of trials over the past decade allowed the inclusion of pregnant women.
The first issue of Elsevier's new open access journal Contemporary Clinical Trials Communications features a new method to make cancer clinical trials more effective, a better way of determining ...
The Phase 2b study demonstrated a statistically significant dose-response relationship at the primary endpoint following a single administration of MM120 across four dose levels, with improvements ...
If you’re seeking to keep politics out of medicine, good luck with that. It isn’t possible. We’ve previously described the political determinants of health (doi:10.1136/bmj.h81),1 and next we’ll focus ...
The National Institute for Health and Care Research (NIHR), the Foreign Commonwealth Development Office (FCDO), and the UK-based global health charity, Wellcome, will co-lead the initiative to help ...
Kyowa Kirin announced it is discontinuing all ongoing clinical trials for rocatinlimab, an investigational anti-OX40 monoclonal antibody, after a safety review identified “emerging concerns” of ...